This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Johns Hopkins University, Ústav Organické Chemie a Biochemie Av {Hacek Over (c)}{hacek Over ( )}R, V.v.i., Ustav Organicke Chemie a Biochemie Av Cr, V.v.i.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3,803 
1 out of 1 
1 out of 38 
Years Active: 2021-2025
Title: Katerina Novotna: Innovator in Glutamine Antagonists
Introduction
Katerina Novotna is a prominent inventor based in Prague, Czech Republic. She has made significant contributions to the field of biochemistry, particularly in the development of glutamine antagonists. With a total of two patents to her name, her work focuses on innovative treatments for various diseases.
Latest Patents
Katerina's latest patents include "Glutamine antagonists and uses thereof." This patent discloses glutamine antagonists and their applications in treating oncological, immunological, and neurological diseases. The methods outlined in her patent involve administering a therapeutically effective amount of a glutamine antagonist to subjects in need of treatment. Additionally, her work includes enhancing the effects of immune checkpoint inhibitors, which can improve patient responses and reduce toxicity associated with these treatments. Another significant patent is for "Prodrugs of glutamine analogs," which includes prodrugs of acivicin, further expanding the therapeutic potential of glutamine analogs.
Career Highlights
Katerina has worked with esteemed institutions such as The Johns Hopkins University and Ústav Organické Chemie a Biochemie AV ČR, V.v.i. Her research has been pivotal in advancing the understanding and treatment of complex diseases through innovative biochemical approaches.
Collaborations
Throughout her career, Katerina has collaborated with notable colleagues, including Barbara S. Slusher and Pavel Majer. These partnerships have contributed to her success and the impact of her research in the scientific community.
Conclusion
Katerina Novotna's contributions to the field of biochemistry, particularly through her patents on glutamine antagonists, highlight her role as an innovator in medical research. Her work continues to pave the way for new treatment options for challenging diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile